Marketing-authorisation holder
GRUNENTHAL ITALIA Srl
40 medicines in 2 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
40 medicines in 2 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 40
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABSTRALCompressa sublinguale | Fentanyl | Italy | Authorised | |
| AXAGONCompressa gastroresistente | Esomeprazole | Italy | Authorised | |
| CONTRAMALCompressa a rilascio prolungato | Tramadol | Italy | Authorised | |
| CRESTORCompressa rivestita con film | Rosuvastatin | Italy | Authorised | |
| CRESTOR 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10,4 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Authorised | 2018 |
| CRESTOR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20,8 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2023 |
| CRESTOR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20,8 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2019 |
| CRESTOR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2020 |
| CRESTOR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20,8 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2018 |
| FLAMINASECompressa rivestita | Promelasi | Italy | Authorised | |
| MICROSERCompressa | Betahistine | Italy | Authorised | |
| NEBIDSoluzione iniettabile | Testosterone | Italy | Authorised | |
| NEO FURADANTINCapsula rigida | Nitrofurantoin | Italy | Authorised | |
| NEXIUMCompressa gastroresistente | Esomeprazole | Italy | Authorised | |
| NEXIUM 10 MG GRANULADO GASTRORRESISTENTE PARA SUSPENSION ORAL, SOBRE10 mg · Granulado para suspensión oral | Esomeprazole | Spain | Authorised | 2025 |
| NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2025 |
| NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2025 |
| NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2024 |
| NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES40 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2025 |
| NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES40 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2025 |
| NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES40 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2025 |
| NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES40 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2024 |
| PALEXIACompressa a rilascio prolungato | Tapentadol | Italy | Authorised | |
| PALEXIACompressa a rilascio prolungato | Tapentadol | Italy | Authorised | |
| PALEXIACompressa a rilascio prolungato | Tapentadol | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 23 | 23 | 0 | CompaniesAll medicines |
| Spain | 17 | 17 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.